Cargando…
Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer
BACKGROUND: Thyroid cancer is the most frequent malignancy of the endocrine system, of which papillary thyroid cancer (PTC) is the predominant form with a rapid increasing incidence worldwide. Rearranged during transfection (RET) fusions are common genetic drivers of PTC and the potent RET inhibitor...
Autores principales: | Chen, Mengke, Xue, Junyu, Sang, Ye, Jiang, Wenting, He, Weiman, Hong, Shubin, Lv, Weiming, Xiao, Haipeng, Liu, Rengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120194/ https://www.ncbi.nlm.nih.gov/pubmed/37081420 http://dx.doi.org/10.1186/s12885-023-10852-z |
Ejemplares similares
-
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
por: Hong, Shubin, et al.
Publicado: (2022) -
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
por: Xue, Junyu, et al.
Publicado: (2021) -
MON-514 Detection of RAS Mutations and RET/PTC Fusions in Thyroid Cancer Using Microfluidic Digital PCR
por: Ylli, Dorina, et al.
Publicado: (2020) -
Durable Disease Control by RET Inhibitor Selpercatinib in a Heavily Pre-Treated RET Fusion-Positive Papillary Thyroid Cancer
por: Yokota, Tomoya
Publicado: (2022) -
Genome-Wide Histone H3K27 Acetylation Profiling Identified Genes Correlated With Prognosis in Papillary Thyroid Carcinoma
por: Zhang, Luyao, et al.
Publicado: (2021)